Your cart is empty.
We would like to inform you that as of today Gaby Bachofner, Head of Corporate Communications and Investor Relations at Tecan Group Ltd, is leaving the company to pursue other interests.
Effective immediately, Christophe Lamps of Rochat & Partners in Geneva will assume responsibility for Tecan Public Relations activities.
If you have any questions concerning Tecan Investor Relations or other business activities, contact details are provided below.
Tecan (www.tecan.com) is a leading player in the fast growing Life Sciences supply industry that specializes in the development, production, and distribution of solutions enabling the discovery of pharmaceutical substances, as well as for genomics, proteomics, and diagnostics. Tecan clients are leading pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2001, Tecan achieved sales of CH 361.9 million (USD 214.1 million; EUR 239.6 million). Registered shares of Tecan Group are traded on the Swiss SWX stock exchange (TK: TECN / Reuters: TECZn.S / Valor : 1210019).
Rochat & Partners
Tel.: +41 (0)22 786 54 55
Fax: +41 (0)22 786 54 58